Clinical usage of intravenous immunoglobulins in Auckland

New Zealand Medical Journal

Volumn 111, Issue 1060, 1998, Pages 48-50

  Lee, Y C ^a   Woodfield, D Graeme ^b   Douglas, Richard ^c  

^a Green Lane Hospital

^b Auckland Regional Blood Centre   (New Zealand)

^c AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ACUTE KIDNEY FAILURE; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOIMMUNE DISEASE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; DRUG COST; DRUG INDICATION; FEVER; GRAFT VERSUS HOST REACTION; GUILLAIN BARRE SYNDROME; HEADACHE; HUMAN; HYPOGAMMAGLOBULINEMIA; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTICENTER STUDY; NEW ZEALAND; THROMBOCYTOPENIA; X LINKED AGAMMAGLOBULINEMIA;

AGAMMAGLOBULINEMIA; BLOOD BANKS; HUMANS; IMMUNIZATION, PASSIVE; NEW ZEALAND; THROMBOCYTOPENIA; TREATMENT OUTCOME; UTILIZATION REVIEW;

EID: 0032570835     PISSN: 00288446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Berkman SA, Lee ML, Gale RP. Clinical uses of intravenous immunoglobulins. Ann Intern Med 1990; 112: 278-92.
2. van der Meche FGA, Schmitz PIM, Dutch Guillain-Barré Study Group. A randomised trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre Syndrome. N Engl J Med 1992; 326: 1123-9.
3. Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia. Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. N Engl J Med 1988; 319: 902-7.
4. Newburger JW, Takahashi M, Beiser AS et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991; 324: 1633-9.
5. Blanchette V, Imbach P, Andrew M, et al. Randomised trial of intravenous immunoglobulin G, intravenous anti-D and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 1994; 344: 703-7.
6. Rostoker G, Desvaux-Belghiti D, Pilatte Y et al. High-dose immunoglobulin therapy for severe IgA nephropathy and Henoch-Schonlein Purpura. Ann Intern Med 1994; 120: 476-84.
7. Kellar T, McGrath K, Newland A, et al. For the Australasian Society of Blood Transfusion. Indications for use of intravenous immunoglobulin. Recommendations of the Australasian Society of Blood Transfusion consensus symposium. Med J Aust 1993; 159: 204-6.
8. Schiff RI. Transmission of viral infections through intravenous immune globulin. N Engl J Med 1994; 331: 1649-50.
9. Sekul EA, Cupler EJ, Dalakas MC. Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors. Ann Intern Med 1994; 121: 259-62.
10. Tan E, Hajinazarian M, Bay W, et al. Acute renal failure resulting from intravenous immunoglobulin therapy. Arch Neurol 1993; 50: 137-9.
11. Dalakas MC. High-dose intravenous immunoglobulin and serum viscosity. Neurology 1994; 44: 223-6.
12. Rosenfeld EA, Shulman ST, Corydon KE, et al. Comparative safety and efficacy of two immune globulin products in Kawasaki disease. J Pediatr 1995; 126: 1000-3.
13. Constantinescu CS, Chang AP, McCluskey LF. Recurrent migraine and intravenous immune globulin therapy. N Engl J Med 1993; 329: 583-4.
14. Tam DA, Morton LD, Stroncek DF, Leshner RT. Neutropenia in a patient receiving intravenous immune globulin. J Neuroimmunol 1996; 64: 175-8.
15. Bjoro K, Friland SS, Yun Z, et al. Hepatitis C infection in patients with primary hypogammaglobulinaemia after treatment with contaminated immune globulin. New Eng J Med 1994; 331: 1607-11.
16. Stiehm ER. Appropriate therapeutic use of immunoglobulin. Transfusion Med Rev 1996; X(3): 203-21.
17. Dennington PM. A review of intravenous immunoglobulin Intragam usage in Queensland, [abstract]. Proceedings of the 30th Annual Scientific Meeting of the Australasian Society of Blood Transfusion; Adelaide, 1996. p191.
18. Schiff RI. Transmission of viral infections through intravenous immune globulin [editorial]. N Engl J Med 1994; 331: 1649-50.
19. Thornton CA, Ballow M. Safety of immunoglobulin. Arch Neurol 1993; 50: 135-6.
20. Bertorini TE, Nance AM, Horner LH, et al. Complications of intravenous gammaglobulin in neuromuscular and other diseases. Muscle Nerve 1996; 19: 388-91.